The 2026 award
Award regulations List of NTD concerned The Previous Awards


THE 2026 AWARD

F
or this ninth edition of the Anne Maurer-Cecchini Award, 8 scientific articles of high value were submitted. We decided to attribute the 2026 Award to an important research study on schistosomiasis conducted in Senegal :

Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis : an open-label, randomized control trial. 


Focusing on bilharzia (or schistosomiasis), the study aims to demonstrate the equivalence of a treatment comprising three doses of a combination of artesunate and mefloquine compared with the standard treatment of a single dose of praziquantel. This is a very sound piece of scientific work based on a cohort of 726 children in Senegal. This study is important, because schistosomiasis affects more than 230 million people worldwide, and control of the disease relies on treating large sections of the population with a single drug, praziquantel, which is vulnerable to the development of resistance.  
(see publication).



   The award was delivered during the closing session of the Geneva Health Forum, November 12, 2026.

The 2028 Anne Maurer-Cecchini Award will be attributed in March - April and announced at the very beginning of the year.





AWARD REGULATIONS

Art. 1
In memory of Anne Maurer-Cecchini, who had decided to work on neglected tropical diseases, the Anne Maurer-Cecchini Foundation creates an award to encourage and sustain research in this field.

Art. 2
The award is normally granted every 2 years to reward, or to finance, clinical or epidemiological research performed in the field of neglected tropical diseases. Its aim is to help the team who accomplished the work to continue its research.

Art. 3
The award is attributed by the foundation committee on the basis of proposals from the scientific committee. The amount, published on the website, is determined at every deadline by the foundation committee.

Art. 4
The scientific committee is designated by the foundation committee; members are chosen amongst specialists in neglected tropical diseases on the basis of their scientific skills. They work on a voluntary basis.

Art. 5
The Anne Maurer-Cecchini award is publicly announced. At every deadline, the committee may give specific details on the research field chosen. Candidates may apply to the scientific committee or the foundation committee by attaching publications about the eligible research work. In order to make a proposal, the scientific committee evaluates the performed work on the basis of published works or works in print.

Art. 6
The award may occasionally be shared between 2 research works judged as equal. It may also be delayed one year in case of absence of eligible application. The award will be delivered, if possible, during a conference attended by the research team.

Art. 7
The decisions taken by the foundation committee concerning the award attribution cannot be appealed and any procedure of appeal or mail exchange on this subject is forbidden. Applying to the Anne Maurer-Cecchini award implies full and complete acceptance of the present regulations. These regulations may be modified at any time. The current version will be available on the foundation website and is the sole authentic version for third parties.

Art. 8
The shared information for the award attribution (except for publications) will neither be published nor divulged by the committee. Names of winners and rewarded works may be quoted and published by the foundation.


Translated from the french version 1.0 dated 12/21/2009 that was approved by the Swiss Governement.

<top>





List of the main Neglected Tropical Diseases targeted by the Anne-Maurer-Cecchini Award


Bacterial infections:

Parasitic infections:

Others :

<top>